Investorideas.com breaking new for AI, drones, GPS and technology

Monday, July 19, 2021

#AIEye #Podcast 581: #Stocks discussed: (NYSE: $ACN) (NasdaqGS: $ZM) (NasdaqGM: $FIVN) #ArtificialIntelligence



 

 

#AIEye #Podcast 581: #Stocks discussed: (NYSE: $ACN) (NasdaqGS: $ZM) (NasdaqGM: $FIVN) #ArtificialIntelligence

 

Accenture Acquires Toronto-based Cloudworks and Zoom Enters Agreement to Acquire Five9

 

Global #AI Market to Reach $299.54B in 2026

 

Point Roberts WA, Vancouver BC – July 19, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/071921-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/07191ACN-ZM-FIVN.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Accenture (NYSE:ACN) has acquired Cloudworks, described in the press release as “a leading Toronto-based Oracle Cloud implementation service provider across North America,” and which boasts “leading capabilities in robotic process automation (RPA), data analytics and AI.” Jeffrey Russell, president of Accenture in Canada, commented:

 

"As organizations across Canada continue to accelerate their technology transformation programs, we anticipate the demand for Oracle solutions to grow significantly. By acquiring Cloudworks, we add a highly talented team with industry-specific experience in combining the power of Oracle with the ingenuity of people to unlock new possibilities for clients."

 

Zoom (NasdaqGS:ZM) has entered into a definitive agreement to acquire Five9, Inc. (NasdaqGM:FIVN) in an all-stock transaction valued at approximately $14.7 billion. Five9 is a leading provider of an intelligent cloud contact center, and this acquisition will give Zoom “access to artificial intelligence tools for analyzing data from a contact center.” Eric S. Yuan, Founder and CEO of Zoom, said:

 

“We are continuously looking for ways to enhance our platform, and the addition of Five9 is a natural fit that will deliver even more happiness and value to our customers. Zoom is built on a core belief that robust and reliable communications technology enables interactions that build greater empathy and trust, and we believe that holds particularly true for customer engagement. Enterprises communicate with their customers primarily through the contact center, and we believe this acquisition creates a leading customer engagement platform that will help redefine how companies of all sizes connect with their customers. We are thrilled to join forces with the Five9 team, and I look forward to welcoming them to the Zoom family.”

 

Global AI Market to Reach $299.54B in 2026

 

A report published by Facts & Factors finds that the global AI market will grow from $29.86 billion in 2020 to $299.64 billion in 2026 with a compound annual growth rate (CAGR) of 35.6 percent in the forecast period. An excerpt from the report’s summary outlines the role of AI in Healthcare as a major market driver:

 

Adoption of AI-based assistance in healthcare during the forecast period is expected to drive the market. Advanced integrated features such as augmenting messages, rapid sorting and enquiring solutions, automated email and phone support, and management of support agents are made possible through the advent of AI. Furthermore, the rising consumer service coupled with increasing spending in the healthcare infrastructure will drive the growth of the artificial intelligence market to a wider range of consumers. Besides healthcare, the essential accelerating pace of advancements in AI and the rising interest in advanced simulation techniques such as artificial neural networks will further fuel the growth of the AI market during the forecast period.

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

 

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 




Get more Technology stock investor ideas - news, articles, podcasts and stock directories

 

Friday, July 16, 2021

#AIEye #Podcast 580: #Stocks discussed: (OTCPINK: $GTCH) (NasdaqGS: $AMZN); #artificialintelligence



 

 

 

#AIEye #Podcast 580: #Stocks discussed: (OTCPINK: $GTCH) (NasdaqGS: $AMZN); #artificialintelligence

 

GBT Launching Larger Scale Testing for qTerm GEN II, and AWS Announces General Availability of ML-Powered Amazon HealthLake

 

#AI #Infrastructure Market to Reach $79.3B by 2026

 

Point Roberts WA, Vancouver BC – July 16, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence    featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/071621-AI-Eye.mp3

 

Read this in full at https://www.investorideas.com/news/2021/artificial-intelligence/07161GTCH-AMZN.asp

 

Hear the Ai Eye on Spotify  

 

Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

 

Stocks discussed: (OTCPINK:GTCH) (NasdaqGS:AMZN)

 

GBT Technologies Inc. (OTC PINK:GTCH) has announced that it is launching larger scale testing for its qTerm GEN II prototype device, which will include a series of enhancements for higher accuracy, consistency and compatibility with a broader spectrum of user's usage and behavior. The company’s CTO, Danny Rittman, explained:

 

"We are expanding our qTerm's testing scale as phase I testing produced very successful results. qTerm GEN II has proven to offer better compatibility for the general population with accurate results and overall reliability. Phase II testing will include a larger number of users within a wider age group, diverse health conditions, lifestyle and occupation. We are interested to learn more about how, where and when people will be using the device, throughout their daily lives. We will evaluate the qTerm prototype for the user's measurement habits and record the data for further analysis. GEN II version improvements significantly increase the device's overall performance, accuracy and consistency. We target the larger scale testing to be used as part of the potential FDA certification process. qTerm's device is planned for personal and telemedicine usages. Based on the larger scale data we expect to fine tune the device's software and mobile application. The device is planned to include an Artificial Intelligence technology that will be offering personal calibration, real-time health statistics and monitoring. One of the major aspects for our larger testing group is to get more data about the devices ease of use and user friendliness aspects. The larger scale testing is planned to take about 30 days, which shortly after, we plan to start creating a commercial version to be handed in. We have a wide variety of potential business partners and customers for qTerm and believe that it can be an efficient health monitoring device. As part of our thorough quality assurance processes we are on a constant mission to ensure the device's highest performance, bringing it to the highest standards and industry's regulations.”

 

Amazon Web Services (AWS), a subsidiary of Amazon (NasdaqGS:AMZN), has announced the general availability of Amazon HealthLake, described in the press release as “a HIPAA [Health Insurance Portability and Accountability Act] eligible service for healthcare and life sciences organizations to ingest, store, query, and analyze their health data at scale,” which employs machine learning. Swami Sivasubramanian, Vice President of Amazon Machine Learning for AWS, said:

 

"More and more of our customers in the healthcare and life sciences space are looking to organize and make sense of their reams of data, but are finding this process challenging and cumbersome. We built Amazon HealthLake to remove this heavy lifting for healthcare organizations so they can transform health data in the cloud in minutes and begin analyzing that information securely at scale. Alongside AWS for Health, we’re excited about how Amazon HealthLake can help medical providers, health insurers, and pharmaceutical companies provide patients and populations with data-driven, personalized, and predictive care."

 

AI Infrastructure Market to Reach $79.3B by 2026

 

A report published by Markets and Markets finds that the global AI Infrastructure market is expected to grow from $23.7 billion in 2021 to $79.3 billion by 2026 with a compound annual growth rate (CAGR) of 27.3 percent in the forecast period. An excerpt from the report’s description outlines the impact of COVID-19 on the market:

 

The COVID-19 pandemic is an accelerator for AI technology, helping people around the world get more and more comfortable with leveraging these tools for many applications, including healthcare. The adoption of remote patient monitoring, decoding genomic sequence for drug development, healthcare chatbots, and enhancement of CT scans using AI technology in diagnosis is expected to gain momentum during and after the COVID-19 pandemic.

Post-COVID-19, the manufacturing sector is expected to adopt smart manufacturing processes using AI, IoT, and blockchain technologies. Companies can reduce costs, increase process efficiency, and reduce human contact significantly by adopting these technologies. Currently, AI is being used for predictive maintenance and will further be implemented to forecast demand and returns in the supply chain.

Several industries are adversely affected by this pandemic, but some industries are benefiting from this pandemic as well. However, the adoption of AI is expected to grow in the coming years.

 

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

The Investorideas.com podcasts are also available on iTunes ( Apple Podcasts) ,  Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com  Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Disclosure: GTCH is a paid featured AI stock on investor ideas

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 




Get more Technology stock investor ideas - news, articles, podcasts and stock directories

New #Stocks to Watch at Investor Ideas in Tech (NYSE: $ZETA) (Nasdaq: $MQ), Biotech (Nasdaq: $JANX) (Nasdaq: $LFST) and Plant-Based (CSE: $YUMY.C)

 New #Stocks to Watch at Investor Ideas in Tech (NYSE: $ZETA) (Nasdaq: $MQ), Biotech (Nasdaq: $JANX) (Nasdaq: $LFST) and Plant-Based (CSE: $YUMY.C)

 

 



 

 

 

 

 

 

 

 

 

Point Roberts WA, Delta BC, July 16, 2021 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading retail investor and trader resource, announces its weekly roundup of stocks to watch in Tech, Biotech and Plant-Based. Today’s stocks have been added to our lists of free stock directories in each sector.

 

Read this in full at https://www.investorideas.com/news/2021/main/07161Stocks.asp

 

The newest tech companies are involved in internet portals/websites, Artificial Intelligence (AI), Cloud computing, Fintech, Software and E-Commerce.

 

The latest biotech companies are involved in biopharmaceuticals, mental health and disease prevention.

 

The newest plant-based company is an affordable health-conscious low-sugar plant-based confectionary company.

 

New Stocks added to Tech Stocks Directory:

nDivision Inc. (OTC:NDVN) provides Autonomic Managed Services and End User Help Desk services to private and public entities, ranging from small businesses to Fortune 500 global enterprises. The Company leverages proprietary intelligent automation technologies to replace expensive human resources. Automation resolves IT issues faster and more accurately than human engineers, driving previously unattainable service levels. The Company manages public clouds, private clouds, and networks across 34 countries and 6 continents, 24-hours a day, 365 days per year. On average, nDivision resolves 83% of all infrastructure incidents using Intelligent Automation with no human involvement, resulting in a 40% to 60% reduction in the cost of IT operations. Customers rate 96% of incidents that nDivision's technical support staff resolve as either "satisfied" or "very satisfied".One of the top ten global solution providers ($90bn+ revenues) resells nDivision's services across the U.S., and a second ($140bn+ revenues) is assisting nDivision with its channel sales strategy through its sponsorship and introductions to a number of large scale partners

 

Zeta Global Holdings Corp. (NYSE:ZETA) is a leading data-driven, cloud-based marketing technology company that empowers enterprises to acquire, grow and retain customers. The Company’s Zeta Marketing Platform (the "ZMP") is the largest omnichannel marketing platform with identity data at its core. The ZMP analyzes billions of structured and unstructured data points to predict consumer intent by leveraging sophisticated artificial intelligence to personalize experiences at scale. Founded in 2007 by David A. Steinberg and John Sculley, the Company is headquartered in New York City

 

Marqeta, Inc. (NasdaqGS:MQ) modern card issuing platform empowers its customers to create customized and innovative payment cards. Marqeta’s modern architecture gives its customers the ability to build more configurable and flexible payment experiences, accelerating time-to-market and democratizing access to card issuing technology. Marqeta’s open APIs provide instant access to highly scalable, cloud-based payment infrastructure that enables customers to launch and manage their own card programs, issue cards and authorize and settle payment transactions. Marqeta is headquartered in Oakland, California and is certified to operate in 36 countries globally.

 

dLocal Ltd (NasdaqGS:DLO) powers local payments in emerging markets connecting global enterprise merchants with billions of emerging market consumers in 29 countries across APAC, the Middle East, Latin America, and Africa. Through the “One dLocal” concept (one direct API, one platform, and one contract), global companies can accept payments, send payouts and settle funds globally without the need to manage separate pay-in and payout processors, set up numerous local entities, and integrate multiple acquirers and payment methods in each market.

 

monday.com Ltd. (NasdaqGS:MNDY) The monday.com Work OS is an open platform that democratizes the power of software so organizations can easily build software applications and work management tools to fit their every need. The platform intuitively connects people to processes and systems, empowering teams to excel in every aspect of their work. monday.com has teams in Tel Aviv, New York, San Francisco, Miami, Chicago, London, Kiev and Sydney. The platform is fully customizable to suit any business vertical and is currently used by over 125,000 customers across over 200 industries in more than 190 countries.    

 

1stdibs.com, Inc. (NasdsaqGS:DIBS) is a leading online marketplace for connecting design lovers with highly coveted sellers and makers of vintage, antique, and contemporary furniture, home décor, art, jewelry, watches and fashion.

 

Kanzhun Ltd (NasdaqGS:BZ) is now the largest online recruitment platform in China in terms of average MAU. We are a pioneer in introducing a disruptive model which is transforming China’s online recruitment industry – the Direct Recruitment Model. Our mobile-native product promotes instant direct chats between Bosses and job seekers, delivers accurate recommendation results, and is powered by proprietary AI algorithms and big data insights. We connect job seekers and enterprise users in an efficient and seamless manner mainly through our highly interactive BOSS Zhipin mobile app, which together with our other mobile apps and mini programs create a vibrant platform covering all kinds of jobseekers (white and gold collar, blue collar and colleague students) and enterprise users (incl. Bosses and recruiting professionals) from various industries within different size of enterprises.

 

NameSilo Technologies (CSE:URL.CNinvests its capital in companies and opportunities, which management believes are undervalued and have potential for significant appreciation. The company makes investments in both public and private markets, and focuses on opportunities in a wide variety of industries, excluding the resource and resource service sectors. Namesilo does not invest on behalf of any third party, and it does not offer investment advice. Namesilo LLC is a low-cost provider of domain name registration and management services. As an accredited ICANN (Internet Corp. for Assigned Names and Numbers) registrar, Namesilo is one of the fastest-growing domain registrars in the world with approximately 3.4 million active domains under management, and over 170,000 active customers from approximately 160 countries.

 

Nanalysis Corp. (TSX:NSCI.V) is an international business focused on capitalizing its proprietary technologies in nuclear magnetic resonance (NMR) that go into NMR spectrometers and magnetic resonance imaging (MRI). Nanalysis operates out of two subsidiaries, Nanalysis Corp. and RS2D S.A.S. (RS2D). Nanalysis Corp. is an industry leader in developing and manufacturing compact NMR spectrometers for laboratory and industrial markets. Its advanced 60 and 100 MHz spectrometers require no liquid helium or other cryogens. These devices are used by chemical professionals spanning a wide variety of industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology. Through its European subsidiary RS2D, the Company's electronic boards and software are used in conventional NMR and MRI equipment and are being incorporated into next-gen MRI systems as well as miniaturized MRI devices.

 

New Stocks added to Biotech Stocks Directory:

Janux Therapeutics, Inc. (NasdaqGS:JANX) is an innovative biopharmaceutical company developing next-generation therapeutics based on its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to better treat patients suffering from cancer. Janux’s initial focus is on developing a novel class of T cell engagers (TCEs), and its lead product candidates are designed to target clinically validated drug targets. While TCE therapeutics have displayed potent anti-tumor activity in hematological cancers, developing TCEs to treat solid tumors have faced challenges due to the limitations of prior TCE technologies, namely (i) overactivation of the immune system leading to cytokine release syndrome, (ii) on-target, healthy tissue toxicities, and (iii) poor pharmacokinetics leading to short half-life. Janux is using its TRACTr platform technology to engineer product candidates designed to overcome these limitations. Janux is developing a broad pipeline with lead programs targeting prostate-specific membrane antigen (PSMA), epidermal growth factor receptor (EGFR), and trophoblast cell surface antigen 2 (TROP2), with all of its programs currently in the IND-enabling or discovery stage.

 

LifeStance Health Group, Inc. (NasdaqGS:LFST) is one of the nation's largest providers of virtual and in-person outpatient behavioral health care for children, adolescents and adults experiencing a variety of mental health conditions. The company delivers personalized, data-driven and comprehensive care to help patients stay healthy and employs over 3,300 psychiatrists, advanced practice nurses, psychologists and therapists. LifeStance Health currently operates across 27 states and over 370 centers.

 

Newtopia (TSX:NEWU.V) is a tech-enabled habit change provider focused on disease prevention and reducing the cost of care for health insurers. As a provider of whole person care, we prevent, reverse, and slow the progression of chronic disease while enriching mental health, resilience and overall human performance. Newtopia's programs leverage genetic, social, and behavioral insights to create individualized prevention programs with a focus on type 2 diabetes, heart disease, stroke and weight. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans and is currently listed on the Toronto Stock Exchange (TSXV: NEWU).

 

New Stocks added to Plant-Based Stocks Directory:

Yumy Bear Goods Inc. (CSE: YUMY) is an affordable health-conscious low-sugar plant-based confectionary company based in Vancouver, British Columbia and it has developed a portfolio of healthier gelatine-free candies made from Non-GMO ingredients with proprietary recipes. All of its products are free of gelatin, soy, gluten, nuts, dairy, eggs, sugar alcohols, artificial sweeteners and genetically modified organisms.

 

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

 

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood, Acorn, Stash and others.

 

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com publishes breaking stock news, third party stock research, guest posts and original articles and podcasts in leading stock sectors.  Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor Idea’s original branded content includes podcasts and columns : Crypto Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast ,  Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and  the AI Eye Podcast.

 

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

 

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Learn more about our news, PR and social media, podcast and ticker tag services at Investorideas.com

https://www.investorideas.com/Investors/Services.asp

 

Learn more about advertising and guest posts

https://www.investorideas.com/Advertise/

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411